SCIENTIFIC EVENTS ORGANISATION

 

Organisation of conferences

  • 16th Conference of the European Society for Toxicology In Vitro, Linz-Austria, 02-04/09/2010.

  • International Gap Junction Conference, Ghent-Belgium, 06-11/08/2011.

  • 17th Conference of the European Society for Toxicology In Vitro, Lisbon-Portugal, 16-19/10/2012.

  • 18th Conference of the European Society for Toxicology In Vitro, Egmond aan zee-The Netherlands, 10-13/06/2014.

  • International Gap Junction Conference, Valparaiso-Chili, 28/03-01/04/2015.

  • 19th Conference of the European Society for Toxicology In Vitro, Juan-Les-Pins-France, 17-21/10/2016.

  • 20th Conference of the European Society for Toxicology In Vitro, Berlin-Germany, 15-18/10/2018.

  • 8th Annual Meeting of the ASCCT: Computational toxicology: peeking into the clouds while keeping our feet on solid ground”, Gaithersburg-USA, 25-26/09/2019.

  • International Industrial and Environmental Toxicology Congress, Antalya-Turkey, 26-29/10/2019.

  • BelTox/IC-3Rs/INVITROM joint symposium, Brussels-Belgium, 21-22/11/2019. 

  • 11th World Congress on Alternatives and Animal Use in the Life Sciences, Maastricht-The Netherlands, 22-26/08/2021.

 

Organisation of conference sessions

  • “Metabolism and toxicokinetics”, 16th Conference of the European Society for Toxicology In Vitro, Linz-Austria, 02-04/09/2010.

  • “Epigenetics”, 8th World Congress on Alternatives and Animal Use in the Life Sciences, Montréal-Canada, 21-25/08/2011.

  • “Carcinogenicity testing” and “Student session”, 17th Conference of the European Society for Toxicology in Vitro, Lisbon-Portugal, 16-19/10/2012.

  • “Connexin-based cellular signalling and its relevance to toxicology”, 49th Conference of the European Societies of Toxicology, Interlaken-Switzerland, 01-04/09/2013.

  • “New molecular biotechnology in toxicology” and “Job opportunity and career exploration”, 18th Conference of the European Society for Toxicology in Vitro, Egmond aan zee-The Netherlands, 10-13/06/2014.

  • “Pathway approaches in toxicology”, 9th World Congress on Alternatives and Animal Use in the Life Sciences, Prague-Czech Republic, 24-28/08/2014.

  • “The role of connexin-based channels in toxicity”, Society of Toxicology Meeting, San Diego-USA, 22-26/03/2015.

  • “Regulation and traffic of hemichannels and gap junction channels”, International Gap Junction Conference, Valparaiso-Chili, 28/03-01/04/2015.

  • “Implementation of the adverse outcome pathway in HeMiBio”, SEURAT Symposium “Painting the future animal-free safety assessment of chemical substances: achievements of SEURAT-1”, Brussels-Belgium, 04/12/2015.

  • “Systemic toxicity” and “Job opportunity and career exploration”, 19th Conference of the European Society for Toxicology in Vitro, Juan-Les-Pins-France, 17-21/10/2016.

  • “Predicting drug-induced cholestatic injury in humans”, Society of Toxicology Meeting, San Antonio-USA, 11-15/03/2017.

  • “Job opportunity and career exploration”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • “Biomarkers in predictive toxicology and risk assessment”, 55th Congress of the European Societies of Toxicology, Helsinki-Finland, 08-11/09/2019.

 

Organisation of workshops and courses

  • Workshop “In vivo extrapolation of in vitro data in toxicology: state-of-the-art and challenges”, Lisbon-Portugal, 20/10/2012.

  • HeMiBio winterschool “Concepts of toxicology and risk assessment”, Barcelona-Spain, 16/01/2013.

  • HeMiBio summerschool “Practical concepts of in vitro and in silico toxicology”, Brussels-Belgium, 04-06/06/2013.

  • 4th ECS workshop “Ca2+ and cell death”, Leuven-Belgium, 11-13/09/2013.

  • SEURAT summerschool, Egmond aan zee-The Netherlands, 07-09/06/2014.

  • HeMiBio winterschool “In vitro biokinetics”, 13/01/2015, Chur-Switzerland.

  • “Applied in vitro toxicology course”, Lisbon-Portugal, 25-29/01/2015.

  • HeMiBio International Symposium “Biology meets technology for liver toxicity testing”, Leuven-Belgium, 02-03/12/2015.

  • “Applied in vitro toxicology course”, Brasilia-Brazil, 20-24/06/2016.

  • “Science Xpression” workshop, La Coruna-Spain, 26-28/09/2016.

  • “Applied in vitro toxicology course”, Belvaux-Luxembourg, 08-13/01/2017.

  • “AOP light course”, Leuven-Belgium, 25/06/2017.

  • “Science Xpression” workshop, Santiago de Compostella/La Coruna-Spain, 25-29/09/2017.

  • “Applied in vitro toxicology course”, Utrecht-The Netherlands, 08-13/04/2018.

  • Continuing Education Course “Organ-specific in vitro modelling: state-of-the-art”, 54th Congress of the European Societies of Toxicology, Brussels-Belgium, 02-05/09/2018.

  • “Science Xpression” workshop, Santiago de Compostella/La Coruna-Spain, 24-28/09/2018.

  • Workshop “AOP: an essential tool in in vitro toxicology”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • Workshop “Hands-on training in vitro and in silico toxicology”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • “ILSI workshop: use of AOPs in safety evaluation of food additives”, Brussels-Belgium, 26-27/02/2019.

  • “Applied in vitro toxicology course”, Bucharest-Romania, 14-19/04/2019.

  • “Molecular Toxicology Course”, Izmir-Turkey, 26-29/06/2019.

  • “Science Xpression” workshop, La Coruna-Spain, 07-11/10/2019.

  • “PANACHE Science Xpression online workshop”, 06-07/10/2020.

  • “Applied in vitro toxicology course”, Brussels-Belgium, 25-30/10/2020.

 

Organisation of seminars and webinars

  • Seminar “Mechanisms of cholestatic liver injury: from animal models to humans”, Brussels-Belgium, 06/09/2018.

  • ASCCT/ESTIV webinar “Stem cell-based in vitro models: state-of-the-art tools to predict drug-induced tissue injury in humans”, 23/10/2018.

  • ASCCT/ESTIV webinars “Pairwise toxicity evaluation of ceramic nanoparticles exposure in human alveolar epithelial A549 cells at submerged and air-liquid cultures” and “Reproducible in vitro toxicology testing using functional immortalized cells”, 23/01/2019.

  • ASCCT/ESTIV webinars “Developing mechanism-based animal toxicity models: a chemocentric approach using big data” and “Integrating genomics and epigenomics into predictive toxicology of the AH receptor”, 20/02/2019.

  • ASCCT/ESTIV webinars “Efficient functional cyst formation of biliary epithelial cells using microwells for potential bile duct organisation in vitro” and “Generation of recombinant human anti-diphtheria toxin neutralizing antibody to replace equine sera”, 20/03/2019.

  • ASCCT/ESTIV webinar “Automated and integrated analysis workflow for adverse outcome pathway identification, hypothesis generation and risk assessment”, 25/04/2019.

  • ASCCT/ESTIV webinar “New computational tools from EPA: the CompTox chemicals dashboard and generalized read-across”, 09/05/2019.

  • ASCCT/ESTIV webinar “GARD™air: an in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning”, 12/06/2019.

  • Applied In Vitro Toxicology Roundtable discussion “Mitochondrial toxicity”, 20/08/2019.

  • ASCCT/ESTIV webinar “Developmental neurotoxicity evaluation: on the road to regulatory acceptance”, 28/08/2019.

  • ASCCT/ESTIV webinar “Nerve-on-a-chip platform for assessing chemotherapy-induced peripheral neuropathy”, 17/09/2019.

  • ASCCT/ESTIV webinar “Translational challenges in in vitro nephrotoxicity models”, 22/10/2019.

  • ASCCT/ESTIV webinar “The pros and cons of 3D in vitro cultures of liver fibrosis”, 04/11/2019.

  • ASCCT/ESTIV webinar “Deep learning in toxicity prediction: reasons for use and possible applications”, 04/12/2019.

  • ASCCT/ESTIV webinars “Role of in vitro mechanistic data for the assessment of endocrine disruptors in the regulatory context” and “A battery of animal-free in vitro assays for evaluating prenatal developmental toxicity potency of highly complex petroleum substances”, 21/01/2020.

  • ASCCT/ESTIV webinar “Moving away from animal testing for acute inhalation toxicity testing”, 25/02/2020.

  • ASCCT/ESTIV webinars “Toxicological mechanistic inference: generating mechanistic explanations of adverse outcomes” and “co-expression network analysis to identify heterogeneity between the breast cancer cell line MCF-7 and human breast cancer tissues”, 11/03/2020.

  • AlterTox Academy webinar "Secrets for winning a grant and coping when losing it", 11/09/2020.

  • EUROTOX in vitro and in silico specialty section webinar "Role of in vitro and in silico methodologies in COVID-19 research", 17/09/2020.